Identification of the antibacterial action mechanism of curcumin on Streptococcus mutans through transcriptome profiling.


Journal

Archives of oral biology
ISSN: 1879-1506
Titre abrégé: Arch Oral Biol
Pays: England
ID NLM: 0116711

Informations de publication

Date de publication:
May 2023
Historique:
received: 28 11 2022
revised: 11 02 2023
accepted: 13 02 2023
pubmed: 27 2 2023
medline: 22 3 2023
entrez: 26 2 2023
Statut: ppublish

Résumé

The purpose of this study was to explore the effect and mechanism responsible for how curcumin affects the biofilm formation by Streptococcus mutans (S. mutans). The antibacterial activity of curcumin was evaluated by measuring the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC). The mass of the biofilm was measured by crystal violet staining. Transcriptome sequencing was used to obtain all the transcript information associated with the biological activity of curcumin-treated S. mutans. Real-time quantitative PCR (qRT-PCR) was performed to examine the expression levels of related biofilm formation genes. The MIC value for curcumin was 64 μM. Curcumin inhibited the formation of a biofilm by S. mutans and degraded mature biofilms. A gene ontology enrichment analysis showed that the DEGs were significantly relevant to biofilm formation. In addition, 17 significantly enriched Kyoto Encyclopedia of Genes and Genomes pathways (p ≤ 0.01) were identified and were potentially associated with the biochemical metabolic processes of S. mutans. DEGs associated with the biofilm formation of S. mutants, including gtfB, gtfC, rgpG, spaP, spxA1, spxA2, bacA, lrgB, and gshAB. The qRT-PCR results were consistent with transcriptome sequencing that the expression levels of gtfB, gtfC, rgpG, and spaP significantly decreased in the curcumin-treated group, whereas the expression levels of spx1, spx2, bacA, lrgB, and gshAB were up-regulated. Curcumin showed marked inhibitory effects against the formation of biofilms by S. mutans and degradation of formed biofilms.

Identifiants

pubmed: 36842372
pii: S0003-9969(23)00043-2
doi: 10.1016/j.archoralbio.2023.105655
pii:
doi:

Substances chimiques

Curcumin IT942ZTH98
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105655

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Li Ke (L)

Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: keli20@whu.edu.cn.

Jiajun Wang (J)

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China; Wuhan Research Center for Infectious Diseases and Tumors of the Chinese Academy of Medical Science, Wuhan, China. Electronic address: zn004070@whu.edu.cn.

Yanhua Liu (Y)

Department of clinical laboratory, Hospital of China University of Geosciences, Wuhan, China. Electronic address: 1261948470@qq.com.

Zhongyi Sun (Z)

Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: sunzhongyi@whu.edu.cn.

Yirong Li (Y)

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China; Wuhan Research Center for Infectious Diseases and Tumors of the Chinese Academy of Medical Science, Wuhan, China. Electronic address: liyirong838@163.com.

Xiao Xiao (X)

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China; Wuhan Research Center for Infectious Diseases and Tumors of the Chinese Academy of Medical Science, Wuhan, China. Electronic address: xiaox1017@whu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH